NYSE · Medical - Devices

CNMD (CNMD) Stock

$44.24 -0.02% NYSE: CNMD Healthcare

Valuation

MetricValue
Price$44.24
Market Cap$1.33B
P/E Ratio19.34
P/B Ratio1.01
P/S Ratio0.75
EPS (TTM)$0.00
52-Week High$56.64
52-Week Low$31.84
Dividend Yield1.17%

Financials & Margins

MetricValue
ROE5.50%
ROA3.71%
ROCE13.65%
Gross Margin53.58%
Operating Margin11.18%
Net Margin4.00%
Debt/Equity0.85
Current Ratio2.14

Annual Financials (USD)

Metric20212022202320242025
Revenue$1.0B$1.0B$1.2B$1.3B$1.4B
Operating Profit$110.0M$70.0M$121.0M$200.0M$141.0M
Net Profit$63.0M$-81.0M$64.0M$132.0M$47.0M
EPS$1.94$-2.68$2.04$4.26$1.51
Op Margin10.9%6.7%9.7%15.3%10.3%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$1.8B$2.3B$2.3B$2.3B$2.3B
Total Liabilities$981.0M$1.6B$1.5B$1.3B$1.3B
Cash$21.0M$29.0M$24.0M$24.0M$41.0M
Borrowings$685.0M$1.1B$991.0M$906.0M$835.0M

Latest News

CNMD: Raising target price to $44.00 Argus Research · Jul 15, 2026 Update: Market Chatter: Conmed Shares Rise After Company Mulls Sale Amid Takeover Interest MT Newswires · Jul 14, 2026 CONMED (CNMD) Stock Trades Up, Here Is Why StockStory · Jul 13, 2026 Conmed Surges Within Striking Distance Of A Breakout On Buyout Rumors Investor's Business Daily · Jul 13, 2026 Why This Medical Technology Stock Is Up 10% Barrons.com · Jul 13, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$112.0M$33.0M$125.0M$167.0M$171.0M
Investing Cash Flow$-30.0M$-271.0M$-39.0M$-26.0M$-41.0M
Financing Cash Flow$3.0M$-185.0M$2.0M$-54.0M$-36.0M
Net Cash Flow$-7.0M$8.0M$-5.0M$0$16.0M
Free Cash Flow$97.0M$12.0M$106.0M$154.0M$151.0M

Valuation & Return Ratios

MetricValue
PEG Ratio1.84
EV / EBITDA8.89
FCF Yield12.00%
Quick Ratio1.04
Interest Coverage4.55
Return 1Y-17.46%
Return 3Y-65.20%
Return 5Y-66.15%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AHCO $11.17 -0.45% 8.52 $1.52B 0.00%
AZTA $29.88 +6.22% -15.22 $1.38B 0.00%
ESTA $92.80 +0.28% -38.58 $2.73B 0.00%
INMD $15.38 +1.38% 9.72 $884.05M 0.00%
KMTS $23.99 +5.08% -3.85 $1.41B 0.00%

About CNMD

CNMD is led by CEO Patrick J. Beyer, employs 3,900 people, headquartered in US, publicly traded since 1987.

CNMD stock trades at $44.24 with a market capitalization of $1.33B. The stock is valued at a price-to-earnings (P/E) ratio of 19.34, price-to-book of 1.01, price-to-sales of 0.75. Over the past 52 weeks the stock has ranged between $31.84 and $56.64, and currently trades 21.9% below its 52-week high. It pays a dividend yielding 1.17%.

On profitability, CNMD generates a return on equity (ROE) of 5.50%, return on capital employed of 13.65%, an operating margin of 11.18%, a net profit margin of 4.00%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNYSE High ROE StocksAll stock screens
Run Stock Screener Investing Guides